|
1
|
Randomized clinical trial of abciximab in diabetic patients undergoing elective percutaneous coronary interventions after treatment with a high loading dose of clopidogrel.
|
Circulation
|
2004
|
3.12
|
|
2
|
Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial.
|
JAMA
|
2005
|
2.53
|
|
3
|
Predictive factors of restenosis after coronary implantation of sirolimus- or paclitaxel-eluting stents.
|
Circulation
|
2006
|
2.18
|
|
4
|
A meta-analysis of 16 randomized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in patients with coronary artery disease.
|
J Am Coll Cardiol
|
2007
|
1.81
|
|
5
|
Meta-analysis of randomized trials on drug-eluting stents vs. bare-metal stents in patients with acute myocardial infarction.
|
Eur Heart J
|
2007
|
1.76
|
|
6
|
Drug-eluting stents compared with thin-strut bare stents for the reduction of restenosis: a prospective, randomized trial.
|
Eur Heart J
|
2005
|
1.68
|
|
7
|
Gender and restenosis after coronary artery stenting.
|
Eur Heart J
|
2003
|
1.62
|
|
8
|
Sirolimus-eluting stents vs paclitaxel-eluting stents in patients with coronary artery disease: meta-analysis of randomized trials.
|
JAMA
|
2005
|
1.57
|
|
9
|
Vessel size and outcome after coronary drug-eluting stent placement: results from a large cohort of patients treated with sirolimus- or paclitaxel-eluting stents.
|
J Am Coll Cardiol
|
2006
|
1.54
|
|
10
|
Culotte stenting technique in coronary bifurcation disease: angiographic follow-up using dedicated quantitative coronary angiographic analysis and 12-month clinical outcomes.
|
Eur Heart J
|
2008
|
1.54
|
|
11
|
Drug-eluting stents versus bare-metal stents in diabetic patients with ST-segment elevation acute myocardial infarction: a pooled analysis of individual patient data from seven randomized trials.
|
Rev Esp Cardiol
|
2009
|
1.45
|
|
12
|
Stem cell mobilization by granulocyte colony-stimulating factor for myocardial recovery after acute myocardial infarction: a meta-analysis.
|
J Am Coll Cardiol
|
2008
|
1.31
|
|
13
|
Randomized trial of paclitaxel- and sirolimus-eluting stents in small coronary vessels.
|
Eur Heart J
|
2006
|
1.18
|
|
14
|
Randomized trial of a nonpolymer-based rapamycin-eluting stent versus a polymer-based paclitaxel-eluting stent for the reduction of late lumen loss.
|
Circulation
|
2006
|
1.13
|
|
15
|
Cost analysis from two randomized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in high-risk patients with coronary artery disease.
|
J Am Coll Cardiol
|
2006
|
1.07
|
|
16
|
Prevention of restenosis by a novel drug-eluting stent system with a dose-adjustable, polymer-free, on-site stent coating.
|
Eur Heart J
|
2005
|
0.91
|
|
17
|
Long-term outcome after sirolimus-eluting stents versus bare metal stents in patients with diabetes mellitus: a patient-level meta-analysis of randomized trials.
|
Clin Res Cardiol
|
2011
|
0.89
|
|
18
|
Relationship between residual blood flow in the infarct-related artery and scintigraphic infarct size, myocardial salvage, and functional recovery in patients with acute myocardial infarction.
|
J Nucl Med
|
2005
|
0.85
|
|
19
|
Everolimus-eluting versus sirolimus-eluting stents: a meta-analysis of randomized trials.
|
Circ Cardiovasc Interv
|
2011
|
0.85
|
|
20
|
A meta-analysis of specifically designed randomized trials of sirolimus-eluting versus paclitaxel-eluting stents in diabetic patients with coronary artery disease.
|
Am Heart J
|
2011
|
0.84
|
|
21
|
Clinical outcome of patients with chronic total occlusion treated with drug-eluting stents.
|
Int J Cardiol
|
2008
|
0.81
|
|
22
|
One year outcomes with abciximab vs. placebo during percutaneous coronary intervention after pre-treatment with clopidogrel.
|
Eur Heart J
|
2005
|
0.79
|
|
23
|
Randomized trial of rapamycin- and paclitaxel-eluting stents with identical biodegradable polymeric coating and design.
|
Eur Heart J
|
2007
|
0.78
|
|
24
|
Clinical outcome of patients with diabetes mellitus and chronic total occlusion treated with drug-eluting stents.
|
J Invasive Cardiol
|
2008
|
0.78
|
|
25
|
Influence of involvement of anterior leaflet versus posterior leaflet on residual regurgitation as assessed by transesophageal echocardiography in patients undergoing valve repair for mitral regurgitation due to mitral valve prolapse.
|
Cardiovasc Ultrasound
|
2009
|
0.75
|
|
26
|
Iron status and clinical outcome in patients with coronary artery disease after coronary stenting.
|
Nutr Metab Cardiovasc Dis
|
2005
|
0.75
|
|
27
|
Sustained increased risk of adverse cardiac events over 5 years after implantation of gold-coated coronary stents.
|
Catheter Cardiovasc Interv
|
2006
|
0.75
|